SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.

Altre lingue Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Deutsche Boerse AG

Azioni

08HH

CNE100001M79

Tempo differito Deutsche Boerse AG Altri mercati azionari 08:04:39 20/05/2024			Variaz. 5gg	Var. 1 gen.
1,546 ^EUR	+0,13%		-0,96%	-19,29%

15/05	L'unità Fosun Pharma Fosun Health riceverà un'iniezione di capitale da Foshan Chanxi City Investment	MT
15/05	La Cina approva le sperimentazioni cliniche per i farmaci contro il cancro al seno	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Fosun Pharma Unit Fosun Health to Receive Capital Injection from Foshan Chanxi City Investment	15/05
China Approves Clinical Trials For Breast Cancer Drugs	15/05
Fosun Pharma Unit Gets China Marketing Approval for Schizophrenia Tablets	10/05
Shanghai Fosun Pharmaceutical Unit Secures China Nod to Sell Schizophrenia Drug	09/05
US FDA Grants Clinical Trial Approval for Fosun Unit's Gastric Cancer Tablets	07/05
Fosun Pharma's Q1 Profit Slumps 38%	30/04
Shanghai Fosun Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04
Fosun Pharma Unit Gets Marketing Registration Approval for Tuberculosis Drug from Chinese Regulator	24/04
China Approves Fosun Unit's Phase 2 Clinical Trial for Cancer Combination Therapy	18/04
Fosun Pharma Unit’s New Drug Application for CMV, HSV Drug Accepted by Chinese Regulator	17/04
Revance to Present New DAXXIFY Data at the American Academy of Neurology 2024 Annual Meeting	15/04
China Accepts New Drug Applications for Fosun Pharma's Iron Overload Syndrome Drugs	08/04
Tranche Update on Shanghai Fosun Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on March 27, 2024.	03/04
Telefield Medical Imaging Limited announced that it has received HKD 59.571525 million in funding Gobi Partners	31/03
Fosun Pharma's 2023 Attributable Profit Declines, Misses Estimates	27/03
Shanghai Fosun Pharmaceutical Co., Ltd. announces an Equity Buyback for CNY 200 million worth of its shares.	27/03
Shanghai Fosun Pharmaceutical Co., Ltd. Proposes Final Dividend for the Year Ended 31 December 2023	26/03
Shanghai Fosun Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	26/03
Shanghai Fosun Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	26/03
Shanghai Fosun Pharma Unit's Oral Schizophrenia Drug Gets Marketing Registration	14/03

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Deutsche Boerse AG

Azioni

08HH

CNE100001M79

Altre lingue

Filtri